Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr;11(4):311-313.
doi: 10.1016/S2213-2600(23)00090-5. Epub 2023 Mar 23.

Advances in tuberculosis control during the past decade

Kogieleum Naidoo  1 , Rubeshan Perumal  2
Affiliations

Advances in tuberculosis control during the past decade

Kogieleum Naidoo et al. Lancet Respir Med. 2023 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

KN receives grants paid to her organisation from the US National Institutes of Health (1R01AI151173, R01AI152142, and1R01AI138646), the European and Developing Countries Clinical Trials Partnership (RIA2019IR-2888), and the Bill and Melinda Gates Medical Research Institute (MRI-TBV01-201 and MRI TBV02-202). She is Chair of the SteerCo Centre for Biomedical Tuberculosis Research, an investigator for the Tuberculosis Transformative Science Group, and is a member of the South African National Tuberculosis Think Tank. RP declares no competing interests.

Comment in

References

    1. Churchyard G, Kim P, Shah NS, et al. What we know about tuberculosis transmission: an overview. J Infect Dis. 2017;216(suppl 6):S629–S635. - PMC - PubMed
    1. Dorman SE, Schumacher SG, Alland D, et al. Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis. 2018;18:76–84. - PMC - PubMed
    1. Calligaro GL, Zijenah LS, Peter JG, et al. Effect of new tuberculosis diagnostic technologies on community-based intensified case finding: a multicentre randomised controlled trial. Lancet Infect Dis. 2017;17:441–450. - PubMed
    1. Churchyard GJ, Stevens WS, Mametja LD, et al. Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF. Lancet Glob Health. 2015;3:e450–e457. - PubMed
    1. Swindells S, Ramchandani R, Gupta A, et al. One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis. N Engl J Med. 2019;380:1001–1011. - PMC - PubMed

Publication types

MeSH terms

Substances